Clinical trials
Phase 1/2 Carcinoma, Ovarian Epithelial trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2016 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| ImmunoVaccine Technologies, Inc. (IMV Inc.) | 1 |
| National Cancer Centre, Singapore | 1 |
| Rutgers, The State University of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 6 |
| Ovarian Neoplasms | 4 |
| Fallopian Tube Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Liver Neoplasms | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.